Press release
Barbiturate Drugs Market is expected to grow to USD 627.71 million by 2032 | Latest Reports by Polaris Market Research
Barbiturate Drugs Market
๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐ซ๐๐ฌ๐ฌ๐๐ฌ:
The global barbiturate drugs market size was valued at USD 462.88 million in 2023 and is expected to grow to USD 627.71 million by 2032.ย
The market is anticipated to exhibit a CAGR of 3.5% during the forecast period from 2024 to 2032.
The market analysis is mainly segmented based on drug type, disease type, distribution channel, and region.
Asia Pacific is projected to witness the fastest growth over the forecast period.
๐๐๐ฉ ๐ข๐ง๐ญ๐จ ๐๐๐ซ๐ค๐๐ญ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐๐ง๐ ๐๐ญ๐๐ฒ ๐๐ก๐๐๐ ๐จ๐ ๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐จ๐ซ๐ฌ - ๐๐๐ญ ๐๐จ๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ฐ! https://www.polarismarketresearch.com/industry-analysis/barbiturate-drugs-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
Barbiturates, which are derivatives of a chemical called barbituric acid, act as central nervous system depressants. They are widely used in the healthcare industry due to their soothing effect on the central nervous system. Clinically, they are prescribed for anxiety and are also effective in the treatment of epilepsy, insomnia, and status epilepticus. Available in pill form, they can be taken orally or intravenously. It's important to note that barbiturates are regulated under the Drug Abuse Prevention and Control Act in the U.S.
๐๐๐ฃ๐จ๐ซ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
Major competitors constantly innovate and differentiate their products in an effort to take the lead in the market. The main companies involved in the barbiturate drugs market have been covered in the report:
Abbott
AbbVie Inc.
Akorn Operating Company LLC
Centurion Healthcare Private Limited
Ethypharm
GlaxoSmithKline plc
Intas Pharmaceuticals Ltd
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Par Pharmaceutical
Pfizer Inc.
Samarth Life Sciences Pvt Ltd
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
๐ ๐ซ๐จ๐ฆ ๐๐๐ญ๐ ๐ญ๐จ ๐๐ข๐ฌ๐๐จ๐ฆ: ๐๐ซ๐๐ง๐ฌ๐๐จ๐ซ๐ฆ ๐๐จ๐ฎ๐ซ ๐๐ฉ๐ฉ๐ซ๐จ๐๐๐ก - ๐๐ฎ๐ฒ ๐๐จ๐ฎ๐ซ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐๐๐ฒ. https://www.polarismarketresearch.com/buy/3368/2
๐๐๐ซ๐๐ข๐ญ๐ฎ๐ซ๐๐ญ๐ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
In 2023, the long-acting barbiturate segment held significant revenue share owing to its wide use in epilepsy, where it helps in controlling seizures.
In 2023, the epilepsy segment held significant revenue share owing to long duration of action, and affordability.
In 2023, the retail pharmacies segment held significant revenue share owing to ease of access, and widespread availability.
In 2023, North America region dominated the global market due to rising prevalence of epilepsy, anxiety, and sleep disorders.
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ:
The barbiturate medicine industry is expanding rapidly due to the increased prevalence of neurological illnesses such as epilepsy and anxiety. Aging populations, lifestyle changes, and more awareness all contribute to an increase in the prevalence of neurological illnesses. Barbiturates, which depress the central nervous system, are increasingly used to manage seizures and relieve anxiety, driving market growth.
๐๐ฅ๐ข๐๐ค ๐ก๐๐ซ๐ ๐ญ๐จ ๐๐๐๐๐ฌ๐ฌ ๐ญ๐ก๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ:ย https://www.polarismarketresearch.com/industry-analysis/barbiturate-drugs-market
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
Polarisย Market Research has segmented the Barbiturate Drugs market report based on drug type, disease type, distribution channel, and region:
Barbiturate Drugs, Drug Type Outlook (Revenueย -ย USD Million, 2019 - 2032)
Long-Acting Barbiturate
Short-Acting Barbiturate
Ultra-Short Acting Barbiturate
Combination Drugs
Barbiturate Drugs, Disease Type Outlook (Revenueย -ย USD Million, 2019 - 2032)
Insomnia
Epilepsy
Sedation
Others
Barbiturate Drugs, Distribution Channel Outlook (Revenueย -ย USD Million, 2019 - 2032)
Hospital Pharmacies
Retail Pharmacies
Others
Barbiturate Drugs, Regional Outlook (Revenue - USD Million, 2019 - 2032)
North America
S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Russia
Asia Pacific
Japan
China
India
Malaysia
Indonesia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
๐ฌ๐๐๐๐๐๐ ๐พ๐๐ ๐-๐๐๐๐๐๐๐ ๐ช๐๐๐๐๐๐๐ ๐๐ ๐ท๐ด๐น'๐ ๐ฏ๐๐๐๐๐๐๐๐๐ ๐ณ๐๐๐ ๐๐๐๐๐:
๐๐ก๐ซ๐จ๐ง๐ข๐ ๐๐๐ฌ๐ญ๐ซ๐ฎ๐๐ญ๐ข๐ฏ๐ ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐๐ซ๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐๐ซ๐ค๐๐ญ:ย https://www.openpr.com/news/3456149/chronic-obstructive-pulmonary-disease-market-is-expected
๐๐๐ซ๐จ๐ฌ๐ญ๐จ๐ฆ๐ข๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ:ย https://www.openpr.com/news/3458114/xerostomia-therapeutics-market-is-expected-to-reach-us-2-94
๐๐๐ซ ๐ ๐๐๐ฅ๐ฅ ๐๐ก๐๐ซ๐๐ฉ๐ฒ ๐๐๐ซ๐ค๐๐ญ:ย https://www.openpr.com/news/3458611/car-t-cell-therapy-market-is-set-to-hit-us-118-680-68-million
๐๐ข๐ซ๐๐ฎ๐ฅ๐๐ญ๐ข๐ง๐ ๐๐ฎ๐ฆ๐จ๐ซ ๐๐๐ฅ๐ฅ๐ฌ ๐๐๐ซ๐ค๐๐ญ:ย https://www.openpr.com/news/3458749/circulating-tumor-cells-market-to-receive-overwhelming-hike
๐๐ง๐ข๐ฆ๐๐ฅ ๐๐๐๐๐ข๐ง๐๐ฌ ๐๐๐ซ๐ค๐๐ญ:ย https://www.openpr.com/news/3458803/animal-vaccines-market-is-expected-to-grow-to-us-31-07-billion
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ง๐๐จ:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Barbiturate Drugs Market is expected to grow to USD 627.71 million by 2032 | Latest Reports by Polaris Market Research here
News-ID: 3543391 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for Barbiturate
Barbiturate Drug Market Size Analysis, Competitive Insights, Leading Players and โฆ
In 2023, the global barbiturate drug market was valued at approximately USD 483 million, and it is projected to grow to about USD 613.7 million by 2032, representing a compound annual growth rate (CAGR) of around 3.0% from 2024 to 2032.
Barbiturate Drug Market Overview
The barbiturate drug market continues to maintain a presence due to its enduring role in treating conditions like epilepsy, insomnia, and sedation-especially in settings where cost-effectiveness andโฆ
Barbiturate Drug Market Size Opportunities and Challenges for the Future
The Barbiturate Drug Market is projected to reach USD 378 million in 2024 and is anticipated to grow to approximately USD 541 million by 2033, registering a CAGR of 4.1% from 2025 to 2033.
Barbiturate Drug Market Overview
The Barbiturate Drug Market is experiencing steady growth, primarily driven by its applications in anesthesia, seizure management, and treatment of severe insomnia. Though the use of barbiturates has declined due to the advent ofโฆ
Barbiturate Drug Market Increasing Demand, Growth Analysis and Future Outlook by โฆ
Global barbiturate drug market is anticipated to grow at a moderate CAGR of 3.5% during the forecast period (2024-2031). The rising prevalence of insomnia along with growing awareness regarding availability of drugs such as barbiturate drug for its easy treatment is a key factor driving the global barbiturate drug market. A study published in April 2020 by the American Journal of Managed Care, states that insomnia is one of theโฆ
Barbiturate Drug Market is Expanding Rapidly with Promising Growth Prospects
Barbiturate Drug Market latest research report added by USD Analytics. The Barbiturate Drug Market Study has been segmented by key a region that is accelerating the marketization. The report is a great blend of qualitative and quantitative market data that was gathered and evaluated mostly through primary data and secondary sources. This also provides the scope of different segments and applications that can potentially influence the marketplace in the future.โฆ
Barbiturate Drugs Market Study Focuses On Current, Future Innovations and Global โฆ
๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:
"Global Barbiturate Drugs Market size and share is currently valued at USD 475.71 million in 2024 and is anticipated to generate an estimated revenue of USD 627.71 million by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 3.5% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032"
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐ฎ๐ซ ๐
๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ @ https://www.polarismarketresearch.com/industry-analysis/barbiturate-drugs-market/request-for-sample
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
Polarisโฆ
Barbiturate Drugs Market Professional Analysis Report 2019| Pfizer, Merck, Eli L โฆ
The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Barbiturate Drugs market. It sheds light on how the global Barbiturate Drugs Market is expected to grow during the course of the forecast period. With SWOT analysis and Porterโs Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global Barbiturate Drugs market and differentโฆ
